Axio Biosolutions

📍 Ahmedabad, India🗓 Founded 2008👥 163 employees💰 Last funded Dec 2019
Medical Equipment Manufacturing🌐 axiobio.com
Website LinkedIn
Axio is a deep-science medical technology company with extensive expertise in biomaterials based medical devices for pre-hospital, intra-operative and post-operative clinical needs. Our focus is on devices for management of trauma, surgical and chronic wounds. Our flagship product, Axiostat, is a patented, clinically validated haemostat that stops moderate to severe bleeding instantly in surgeries and in pre-hospital trauma. Axiostat is USFDA 510(k) cleared and is also European CE approved. In Advanced Wound Care range, Axio has launched the next-generation MaxioCel wound dressing. MaxioCel is designed to heal patients suffering from acute and chronic wounds (diabetic foot ulcers, pressure ulcers, burns, bed sores, cavity wounds and surgical site infections) by effectively managing exudates, pain reduction and scar less healing. All Axio products are manufactured in state-of-the-art ISO 13485 and GMP certified facility.
3
Total investors
0
Early stage
0
Mid stage
1
Late stage
2008
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
India
2
Singapore
1
Investor activity2015–2019 · investors recorded per year
2015120192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Axio Biosolutions?
Axio Biosolutions has 3 investors on record on gritt.io and 1 late-stage investors.
When did Axio Biosolutions last raise funding?
The most recent investment in Axio Biosolutions recorded on gritt.io was in December 2019.
When was Axio Biosolutions founded?
Axio Biosolutions was founded in 2008.
What industry is Axio Biosolutions in?
Axio Biosolutions operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Axio Biosolutions based?
Axio Biosolutions is headquartered in Ahmedabad, India.